Zobrazeno 1 - 10
of 73
pro vyhledávání: '"W. Seiferheld"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
W.A. Hall, S. Pugh, A. Pollack, C.A.F. Lawton, D.E. Spratt, J.A. Efstathiou, T.M. Morgan, R.R. Mckay, J. Simko, A.G. Martin, J.M. Michalski, A. Balogh, H. Lukka, S. Faria, M. Hagerty, M.C. Beauchemin, R.J. Lee, S.A. Seaward, W. Seiferheld, F.Y. Feng
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:S36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27b407eda1c80b44b9373e477704ae8d
https://doi.org/10.1016/j.ijrobp.2022.07.396
https://doi.org/10.1016/j.ijrobp.2022.07.396
Autor:
William C. Jackson, Robert T. Dess, W. Seiferheld, William U. Shipley, Kenneth L. Zeitzer, H. Lukka, Zachary S. Zumsteg, Anthony L. Zietman, M.J. Schipper, D.E. Spratt, R.D. Lovett, Ming Tang, William A. Hall, Alexander Balogh, H.M. Sandler, Jason A. Efstathiou, Thomas M. Pisansky, Jean-Paul Bahary, F.Y. Feng
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 108:S63-S64
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a98f1098e1ba7b02fc7c4d49eb9e0574
https://doi.org/10.1016/j.ijrobp.2020.07.2197
https://doi.org/10.1016/j.ijrobp.2020.07.2197
Autor:
W. Seiferheld, Felix Y. Feng, Albert J. Chang, Michael L. Steinberg, Paul C. Boutros, Amar U. Kishan, Sandy T. Liu, Michel Bolla, Paul L. Nguyen, Christopher R. King, Stephanie E. Pugh, Nicholas G. Nickols, Dipti Sajed, Fang-I Chu, Howard M. Sandler, Phuoc T. Tran, Patrick A. Kupelian, Robert E. Reiter, Kiri A. Sandler, David Elashoff, Laurence Collette, Matthew Rettig, Alexandra Drakaki, Xiaoyan Wang, Philippe Maingon, Daniel E. Spratt, Theo M. de Reijke
Publikováno v:
Transl Androl Urol
European urology, 77(2), 201-208. Elsevier
European urology, vol 77, iss 2
European urology, 77(2), 201-208. Elsevier
European urology, vol 77, iss 2
Background: The importance of local failure (LF) after treatment of high-grade prostate cancer (PCa) with definitive radiotherapy (RT) remains unknown. Objective: To evaluate the clinical implications of LF after definitive RT. Design, setting, and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4908712dd5b0910514e2e0a812c34dc
https://pubmed.ncbi.nlm.nih.gov/32676383
https://pubmed.ncbi.nlm.nih.gov/32676383
Autor:
Deborah Watkins Bruner, Leonard G. Gomella, Alexander Balogh, André-Guy Martin, W. Seiferheld, R. Jeffrey Lee, Jeff M. Michalski, Aaron M. Allen, Drew C. Monitto, Jeffrey S. Wefel, Daniel A. Low, George Rodrigues, Marie-Claude Beauchemin, Howard M. Sandler, Himansu Lukka, Steve Angyalfi, Sergio Faria, Alan Pollack, Petah Tikva, Samantha A. Seaward, Theodore Karrison
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:Salvage prostate bed radiotherapy (PBRT) results in about 70% 5 yr freedom from progression (FFP). A three arm randomized trial was designed to determine whether there a...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7dbd18b5d3808332987e79192bc61d8
https://doi.org/10.1097/01.ju.0000557133.04919.da
https://doi.org/10.1097/01.ju.0000557133.04919.da
Autor:
Jason A. Efstathiou, Paul L. Nguyen, William A. Hall, H. Lukka, James J. Dignam, Jeffry P. Simko, Huei-Chung Huang, W. Seiferheld, Felix Y. Feng, Amit I. Shah, Elai Davicioni, William U. Shipley, Phuoc T. Tran, Daniel E. Spratt, Jean-Paul Bahary, Stephanie L. Pugh, Alan Pollack, Adam P. Dicker, Thomas M. Pisansky, Howard M. Sandler
Publikováno v:
Journal of Clinical Oncology. 38:276-276
276 Background: Decipher is a genomic classifier (GC) that estimates risk of prostate cancer (PCa) distant metastases (DM) post-radical prostatectomy (RP). Herein, we validate the GC within the context of a randomized phase 3 trial. Methods: RP speci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1647da5c85587abda32ee61271a9aa0d
https://doi.org/10.1200/jco.2020.38.6_suppl.276
https://doi.org/10.1200/jco.2020.38.6_suppl.276
Autor:
Anthony L. Zietman, Niall M. Heney, Stephanie L. Pugh, David J. Grignon, William U. Shipley, Howard M. Sandler, James J. Dignam, Richard Dana Lovett, Seth A. Rosenthal, Oliver Sartor, Kenneth L. Zeitzer, W. Seiferheld, Pierre Major, Felix Y. Feng, H. Lukka, Maltibehn P. Patel, Colleen A. Lawton, Luis Souhami, Kevin J. Kerlin, Thomas M. Pisansky, Alexander Balogh, Jean Paul Bahary
Publikováno v:
The New England journal of medicine. 376(5)
Salvage radiation therapy is often necessary in men who have undergone radical prostatectomy and have evidence of prostate-cancer recurrence signaled by a persistently or recurrently elevated prostate-specific antigen (PSA) level. Whether antiandroge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::206fe94b5422d55bf5155658e9506d9f
https://pubmed.ncbi.nlm.nih.gov/28854468
https://pubmed.ncbi.nlm.nih.gov/28854468
Autor:
A.U. Kishan, W. Seiferheld, R.E. Reiter, Michael L. Steinberg, Nicholas G. Nickols, C.R. King, L. Collette, Fang-I Chu, M. Rettig, H.M. Sandler, Albert J. Chang, Stephanie L. Pugh, T.M. De Reijke, P.A. Kupelian, Kiri A. Sandler, M. Bolla, Alexandra Drakaki, Xiaoyan Wang, Philippe Maingon, Sandy T. Liu
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 102:S145-S146
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfaae63b659ac8218b8c6dd2c6d7df78
https://doi.org/10.1016/j.ijrobp.2018.06.353
https://doi.org/10.1016/j.ijrobp.2018.06.353
Autor:
Kiri A. Sandler, Matthew Rettig, Robert E. Reiter, Nicholas G. Nickols, Theo M. de Reijke, Alexandra Drakaki, W. Seiferheld, Xiaoyan Wang, Christopher R. King, Michel Bolla, Michael L. Steinberg, Howard M. Sandler, Gerald E. Hanks, Philippe Maingon, Daniel E. Spratt, Laurence Collette, Amar U. Kishan, Patrick A. Kupelian
Publikováno v:
JAMA oncology, 5(1), 91-96. American Medical Association
IMPORTANCE: Androgen deprivation therapy (ADT) improves survival outcomes in patients with high-risk prostate cancer (PCa) treated with radiotherapy (RT). Whether this benefit differs between patients with Gleason grade group (GG) 4 (formerly Gleason
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c45280f4cde40d97a2df9bd0782a2207
https://doi.org/10.1001/jamaoncol.2018.3732
https://doi.org/10.1001/jamaoncol.2018.3732
Autor:
H. Lukka, Jeffrey S. Wefel, E. Vigneault, W. Seiferheld, Marie-Claude Beauchemin, A.G. Balogh, H.M. Sandler, Aaron M. Allen, Deborah Watkins Bruner, J.M. Michalski, Leonard G. Gomella, Daniel A. Low, Theodore Karrison, George Rodrigues, S. Angyalfi, Samantha A. Seaward, Alan Pollack, Sergio Faria, D.C. Monitto
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 102:1605
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3069cdb6c5e6f9787387dc96b064d979
https://doi.org/10.1016/j.ijrobp.2018.08.052
https://doi.org/10.1016/j.ijrobp.2018.08.052